Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
11/26/1992 | WO1992020674A1 1h-imidazol-1-yl-methyl benzofuran derivatives, with the imidazolyl moiety being substituted by a cycloalkyl group |
11/26/1992 | WO1992020673A1 Antihypotensive benzofuran derivatives with n-linked 1h-imidazolylmethyl-5-carboxamide substituents |
11/26/1992 | WO1992020651A2 N-(heteroaryl)-imidazolyl-alkenoic acids |
11/26/1992 | WO1992020643A1 Novel bi-aromatic compounds derived from a salicilic pattern, method of preparation and use in human and veterinary medecine and in cosmetics |
11/26/1992 | WO1992016198A3 Method and products for treating the eye |
11/24/1992 | US5166175 Treatment of ocular hypertension with a synergistic combination |
11/19/1992 | EP0514264A1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics |
11/19/1992 | EP0514216A1 Antihypotensive benzofuran derivatives with N-linked 1H-imidazolyl-methyl-5-carboxamide substituents |
11/19/1992 | EP0514198A1 1H-Imidazol-1-yl-methyl benzofuran derivatives with the imidazolyl moiety being substituted by a cycloalkyl group |
11/19/1992 | EP0514192A1 Antihypertensive benzofuran derivatives, substituted by varied N-pyrimidinyl- or N-imidazolyl-methyl groups |
11/19/1992 | EP0514126A1 Benzodiazepine analogs |
11/19/1992 | EP0514125A1 Triazolobenzodiazepines |
11/19/1992 | EP0514009A1 Corneal treatment agents |
11/19/1992 | EP0513979A1 Angiotensin II antagonists incorporating a substituted thiophene or furan |
11/18/1992 | WO1992020648A1 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives |
11/18/1992 | CA2102295A1 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives |
11/17/1992 | US5164407 Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists |
11/17/1992 | US5164372 Treatment of respiratory disorders, inflammation, dermatitis |
11/17/1992 | US5164194 Treatment of irritated eye and nose mucous membranes resulting from a cold or allergy |
11/17/1992 | CA2068779A1 Benzofuran derivatives |
11/17/1992 | CA2068766A1 Benzofuran derivatives |
11/15/1992 | CA2068434A1 Benzodiazepine analogs |
11/15/1992 | CA2068433A1 Triazolobenzodiazepines |
11/12/1992 | WO1992019278A1 Use of macrolide compounds for eye diseases |
11/12/1992 | WO1992017426A3 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
11/11/1992 | WO1992021049A1 Methods and compositions for inhibiting deposit formation on contact lenses |
11/11/1992 | WO1992020662A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
11/11/1992 | WO1992020660A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists |
11/11/1992 | EP0512952A1 Octahydrobenzo (G) quinoline |
11/11/1992 | EP0512870A1 Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists |
11/11/1992 | EP0512676A1 Angiotensin II antagonists incorporating a substituted benzyl element |
11/11/1992 | EP0512675A1 Angiotensin II antagonists incorporating a substituted thiophene or furan |
11/11/1992 | EP0298134B1 Aromatic heterocyclic carboxylic acid amide derivatives, process for their preparation, and pharmaceutical composition containing same |
11/11/1992 | CA2109524A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
11/11/1992 | CA2109205A1 Methods and compositions for inhibiting deposit formation on contact lenses |
11/11/1992 | CA2102802A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists |
11/11/1992 | CA2068229A1 Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists |
11/10/1992 | US5162370 Treatment of cataract with prostacyclin compounds |
11/10/1992 | US5162340 Hypotensive agents, treatment of congestive heart failure |
11/10/1992 | US5162325 Angiotensin ii antagonists incorporating a substituted benzyl element |
11/10/1992 | US5162316 Pyrimido[4,5-d]pyrimidine derivatives for use as bronchodilators |
11/08/1992 | CA2063895A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan |
11/08/1992 | CA2063752A1 Angiotensin ii antagonists incorporating a substituted benzyl element |
11/03/1992 | CA2067648A1 Octahydrobenzo[g]quinoline |
10/29/1992 | WO1992018486A1 Improved process for the preparation of [1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide |
10/29/1992 | WO1992018461A1 Ethanolamine derivatives with anti-pollakiuria activity |
10/29/1992 | WO1992018124A1 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST |
10/29/1992 | WO1992010193A3 Homo-prostaglandin derivatives as ocular hypotensives |
10/29/1992 | CA2106673A1 Improved process for the preparation of [1s-(1r*,2s*,3r*)]-n-(4-morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide |
10/28/1992 | EP0510812A1 Angiotensin II antagonists incorporating a substituted thiophene or furan |
10/28/1992 | EP0510186A1 Therapeutic uses of melanin |
10/28/1992 | EP0221958B1 3-aminopropyloxyphenyl derivatives their preparation and pharmaceutical compositions containing them |
10/27/1992 | CA2063856A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan |
10/27/1992 | CA1309348C Ophthalmic composition containing polysiloxane |
10/24/1992 | CA2066842A1 Corneal treatment agents |
10/23/1992 | WO1992018163A1 Medicine for intraocular operation |
10/23/1992 | CA2085732A1 Pharmaceutical composition for use in intraocular surgery |
10/21/1992 | EP0509752A2 Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist |
10/21/1992 | EP0509598A1 Use of ibopamine for the manufacture of a pharmaceutical composition for the treatment of glaucomatous optic neuropathy |
10/20/1992 | WO1992018543A1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use |
10/20/1992 | US5157140 Esters of myo-inositol phosphate |
10/20/1992 | US5157129 Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide |
10/20/1992 | US5157044 Analogs of carbonic anhydrase inhibitors and their use as topical IOP inhibitors |
10/20/1992 | US5157040 Substituted quinolines as angiotensin ii antagonists |
10/20/1992 | US5156601 Blend of polyurethane and decyclized poly(N-vinyl lactam) |
10/17/1992 | WO1992018513A1 New non-hygroscopic mono-ammonium salts |
10/15/1992 | WO1992017174A1 Process for preparing aqueous suspension |
10/15/1992 | WO1992008465A3 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
10/15/1992 | CA2083842A1 Method for preparation of an aqueous suspension |
10/14/1992 | EP0508799A1 Cholecystokinin antagonists |
10/14/1992 | EP0508798A1 Cholecystokinin antagonists |
10/14/1992 | EP0508797A1 Cholecystokinin antagonists |
10/14/1992 | EP0508796A1 Cholecystokinin antagonists |
10/14/1992 | EP0508690A1 Tetronic and thiotetronic acid derivatives |
10/13/1992 | US5155259 Aldose reductase inhibitor |
10/13/1992 | CA2065228A1 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
10/11/1992 | CA2065715A1 Cholecystokinin antagonists |
10/11/1992 | CA2065704A1 Cholecystokinin antagonists |
10/11/1992 | CA2065703A1 Cholecystokinin antagonists |
10/07/1992 | EP0507594A1 Substituted quinolines as angiotensin II antagonists |
10/07/1992 | EP0507224A2 Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
10/07/1992 | EP0506840A1 Method of treating ocular diseases by periocular administration of cyclosporine a or g |
10/07/1992 | CN1065009A Process for preparing composition for beauty or pharmaceutical, especially dermtoses and anti-allergy and use |
10/06/1992 | US5153205 Method to reduce introacular pressure without causing miosis |
10/06/1992 | US5153192 For controlling intraocular pressure |
10/06/1992 | CA2064654A1 Substituted quinolines as angiotensin ii antagonists |
10/01/1992 | WO1992016199A1 Method and products for treating the eye |
10/01/1992 | WO1992016198A2 Method and products for treating the eye |
10/01/1992 | WO1992016104A1 Leukotriene antagonists |
09/30/1992 | EP0506300A2 Tacky, hydrophilic gel dressings and products therefrom |
09/27/1992 | WO1992017426A2 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
09/27/1992 | CA2105158A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
09/27/1992 | CA2063866A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan |
09/26/1992 | WO1992016551A1 Small peptidic compounds useful for the treatment of glaucoma |
09/26/1992 | WO1992016550A1 Organosulphur compounds useful for the treatment of glaucoma |
09/26/1992 | CA2106860A1 Organosulphur compounds useful for the treatment of glaucoma |
09/26/1992 | CA2106858A1 Small peptidic compounds useful for the treatment of glaucoma |
09/23/1992 | EP0505111A2 Angiotensin II antagonists incorporating a substituted imidazo (1,2-b)(1,2,4) triazole |
09/23/1992 | EP0505098A1 Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists |
09/23/1992 | CA2063494A1 Angiotensin ii antagonists incorporating a substituted imidazo (1,2-b)(1,2,4) triazole |